NIH-funded research R37 grant

Understanding how the gut protects itself from inflammation caused by TNF

Official title: Novel mechanisms protecting the gut from TNF

Funded at Weill Medical Coll of Cornell Univ · NIH-11249770 · Data updated 2026-11-12

This study is looking at how certain immune cells in your gut help protect against damage and inflammation caused by a protein called TNF, which is important for people with inflammatory bowel disease (IBD), to find new ways to help manage gut health.

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startJuly 18, 2023
Project endJune 13, 2025
Funding year2025
Award (this year)$69,910
NIH project number3R37AI174468-02S1
Project IDNIH-11249770 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with inflammatory bowel disease or those experiencing chronic gut inflammation.

Less likely to help

Patients with non-inflammatory gastrointestinal conditions may not receive any benefit from this research.

What this research studies

This research investigates how the gut can defend itself against damage and inflammation caused by a protein called TNF. It focuses on a specific type of immune cell, known as group 3 innate lymphoid cells (ILC3s), which play a crucial role in maintaining gut health. The researchers aim to uncover the mechanisms by which these cells produce protective substances that help balance the effects of TNF, especially in conditions like inflammatory bowel disease (IBD). By understanding these processes, the research hopes to identify new therapeutic strategies for patients suffering from chronic gut inflammation.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that better protect the gut from inflammation and improve outcomes for patients with inflammatory bowel disease.

How similar studies have gone: Previous research has shown promise in understanding immune responses in the gut, but this specific approach focusing on ILC3s and their protective mechanisms is relatively novel.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Sonnenberg, Gregory F — Weill Medical Coll of Cornell Univ
  • Study coordinator: Sonnenberg, Gregory F

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.